Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
10/2008
10/15/2008EP1296995B1 3'-prodrugs of 2'-deoxy-beta-l-nucleosides
10/15/2008EP1272515B1 Immunoregulator
10/15/2008EP1200116B1 USE OF FVIIa OR A TISSUE FACTOR AGONIST FOR REGULATING GENE EXPRESSION AND CELL MIGRATION OR CHEMOTAXIS
10/15/2008EP1173432B9 Piperidine-indole compounds having 5-ht6 affinity
10/15/2008EP1126826B1 Multiparticulate modified release composition of methylphenidate
10/15/2008EP1045906B1 Apo-2 ligand
10/15/2008EP1019057B1 A method of preventing or treating estrogen-dependent diseases and disorders
10/15/2008CN101287458A Composition for use in prevention of hypoglycemic condition
10/15/2008CN101284865A New compound and its medicine use
10/15/2008CN101284808A Compounds and methods for the inhibition of the expression of VCAM-1
10/15/2008CN101284137A Nm gene formulations for promoting mink growing
10/15/2008CN101284041A Compound radix astragali Chinese medicinal formulations with health-care function and preparation technique
10/15/2008CN101284005A Application of indirubin for preparing medicine for preventing blood vessel from regenerating
10/15/2008CN101283996A Application of clock wise D-methionine in preparing the medicine for preventing and curing the myelosuppression induced by radiation
10/15/2008CN100425600C Benzothiazole- and benzoxazole-4,7-dione derivatives and their use as CDC25 phosphatase inhibitors
10/15/2008CN100425286C Purified ustading and its preparation method and medicinal composition containing said ustading
10/15/2008CN100425258C Compound Chinese medicine composition and its prepn and use
10/15/2008CN100425249C Anti-fatigue health products and its preparation method
10/15/2008CN100425241C Glaucoma-treating agent consisting of RHo kinase inhibitor and prostaglandin
10/15/2008CN100425169C Chinese herbal health-caring beverage
10/15/2008CN100425146C Higher unsaturated fatty acid composition
10/14/2008US7435834 2-thia-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
10/14/2008US7435832 Preparing an anhydrous crystal of a malic acid salt of N-[2-(diethylamino)ethyl]-5-[(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide by reacting the acid and amine in a solvent and crystallizing under various process conditions
10/14/2008US7435814 N4-(1,4-Benzoxazin-6-yl)-5-fluoro-N2-[3-(N-methylamino)carbonylmethyleneoxyphenyl]-2,4-pyrimidinediamine or a salt, hydrate, solvate and/or N-oxide; inhibit the IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators; Syk kinase inhibitors
10/14/2008US7435750 Method of using substituted 3-aryl-5-aryl-[1,2,4]-oxadiazoles and analogs as activators of caspases and inducers of apoptosis and the use thereof
10/14/2008US7435747 Guanidine and amidine derivatives as factor Xa inhibitors
10/14/2008US7435744 Brain disorders; central nervous system disorders; viricides
10/14/2008US7435743 I kappa B kinase beta inhibitors that are 2-amino-4,6-disubstituted nicotinic acid ester analogs; antiinflammatory, antitumor and antiischemic effects; asthma; nuclear factor kappa B inhibitors; 7-(2-hydroxyphenyl)-5-(3-piperidinyl)-1,4-dihydro-2H-pyrido[2,3-d][1,3]oxazin-2-one
10/14/2008US7435742 potent antagonists of M3 muscarinic receptors; chronic obstructive pulmonary disease; bronchitis, bronchial hyperreactivity, asthma, cough and rhinitis; gastrointestinal disorders; incontinenc; [2-(3,4-Dimethoxyphenyl)ethyl]-(5-methylfuran-2-ylmethyl)carbamic acid (3R)-1 -azabicyclo[2.2.2]oct-3-yl ester
10/14/2008US7435737 4-(1-Piperazinyl)-2(1H)-quinolone and 4-(1-piperazinyl)quinoline derivatives, e.g., 3-nitro- or 3-alkoxycarbonyl-1-methyl-4-[4-thiophene-2-carbonyl)-piperazine-1-yl]-1H-quinolin-2-one; antitumor and angiogenesis inhibitor, antiinflammatory, antidiabetic agent, autoimmune disorder
10/14/2008US7435734 Such as N-(2-ethoxybenzyl)-5-hydroxy-1-methyl-2-(4-methylphenyl)-6-oxo-1,6-dihydropyrimidine-4-carboxamide; inhibitors of HIV replication; with other HIV/AIDS antivirals, anti-infectives, immunomodulators, antibiotics or vaccines; AIDS
10/14/2008US7435729 using estrogen antagonist ; anticancer agents
10/14/2008US7435726 Thalidomide and a topoisomerase inhibitor anticancer drug such as irinotecan; reduces toxicity related side effects of anticancer drug
10/14/2008US7435725 Oral compositions and methods for prevention, reduction and treatment of radiation injury
10/14/2008US7435595 Using prokaryotic histone protein as tool in transfer of heterologus nucleotide sequences into cells; improving exogenous gene expression
10/14/2008US7435583 Membrane fractions of 1,2-sn-diacylglycerol-enriched cells
10/14/2008US7435547 Injectable or oral administration of a drug with an active ingredient of an extract from inflamed cutaneous tissue of rabbits inoculated with vaccinia virus; side effect reduction
10/14/2008US7435410 Methods of treatment with interferson and albumin fusion protein
10/14/2008CA2497345C Novel quaternary ammonium compounds
10/14/2008CA2494177C Azulene derivatives and salts thereof for use as na+-glucose cotransporter inhibitors
10/14/2008CA2445145C Carboxylic acid substituted oxazole derivatives for use as ppar-alpha and -gamma activators in the treatment of diabetes
10/14/2008CA2419279C Prodrugs to nmda receptor ligands
10/14/2008CA2387727C Benzopyranyl guanidine derivatives, process for preparation thereof, and pharmaceutical compositions containing them
10/14/2008CA2382880C N-cyclopentyl modulators of chemokine receptor activity
10/14/2008CA2338680C Medicinal aerosol formulations
10/14/2008CA2331395C Fatty acid analogues for the treatment of diabetes
10/14/2008CA2330359C Reduction of postoperative complications of cardiopulmonary bypass (cpb) surgery
10/14/2008CA2322380C Method of preventing the death of retinal neurons and treating ocular diseases
10/14/2008CA2309328C Cyclic amine derivatives and their use as drugs
10/14/2008CA2288821C Modulation of human mast cell activation
10/14/2008CA2280310C Nmda antagonist
10/14/2008CA2255865C Synthesis of soluble beta-sheet forming peptides
10/14/2008CA2171625C Oxidized carotenoids, retinoids and related conjugated polyenes, and derived fractions and compounds useful as cell-differentiation inducers, cytostatic agents, and anti-tumor agents
10/09/2008WO2008121449A2 A system and method of acquiring instant credit
10/09/2008WO2008121352A2 Crystal forms of (r) -n-methylnaltrexone bromide and uses thereof
10/09/2008WO2008121348A2 Peripheral opioid receptor antagonists and uses thereof
10/09/2008WO2008121331A1 Materials and methods for treating nerve damage and promoting nerve repair and regeneration
10/09/2008WO2008121329A2 Turkey herpesvirus vectored recombinant containing avian influenza genes
10/09/2008WO2008121126A1 Non-peptidic molecules for detecting and treating tumors
10/09/2008WO2008120818A1 Indole derivative having cpla2 inhibitory activity, use of the same and method for producing the same
10/09/2008WO2008120815A1 Targeting agent for cancer cell or cancer-associated fibroblast
10/09/2008WO2008120813A1 Combined use of dipeptidyl peptidase iv inhibitor compound and sweetener
10/09/2008WO2008120797A1 Ampk activator
10/09/2008WO2008120778A1 Composition for promoting ketone compound formation
10/09/2008WO2008120765A1 Analgesic composition
10/09/2008WO2008120759A1 Urea compound and use thereof
10/09/2008WO2008120754A1 Picolinamide compound
10/09/2008WO2008120744A1 Five-membered cyclic amide compound and use thereof
10/09/2008WO2008120725A1 Novel pyrrolinone derivative and medicinal composition containing the same
10/09/2008WO2008120720A1 Dentinogenesis promoter and dentinogenic pulp-capping material
10/09/2008WO2008120708A1 Engraftment enhancer or proliferation enhancer in tissue plantation
10/09/2008WO2008120661A1 Novel fused pyrrole derivative
10/09/2008WO2008120655A1 Oxazolidinone derivative having inhibitory activity on 11β-hydroxysteroid dehydrogenase type i
10/09/2008WO2008120653A1 Indoledione derivative
10/09/2008WO2008120551A1 Apoptosis inhibitor
10/09/2008WO2008120542A1 Food composition having the form of solid preparation comprising plant polygonum aviculare as active ingredient
10/09/2008WO2008120472A1 Prophylactic and/or therapeutic agent for hyperlipemia
10/09/2008WO2008119127A1 Herbal compositions and methods for treating menorrhagia
10/09/2008WO2008065444B1 Substituted quinazolines
10/09/2008US20080249298 use of heparinoid derivatives for the treatment and diagnosis of disorders which can be treated with heparinoids
10/09/2008US20080249188 Methods and devices for non-invasive cerebral and systemic cooling
10/09/2008US20080249185 Alleviating acute alcohol intoxication/side effects of a hangover by administering, for example, 2,3-dimercapto-1-propanol; food additives/supplements; animal feed; oxidation resistance; immunostimulants; demetallization; shelf life cosmetology; dermatology; food additives/supplements; feeds; drugs
10/09/2008US20080249178 Administering magnesium thronate to achieve a phsiological concentration of magnesium of >0.75 as determined under fasting conditions; enhancing synaptic plasticity; health, nutrients, cognition activators; Alzheimer's disease;, attention deficit hyperactivity disorder; and other nervous system disorders
10/09/2008US20080249171 Administering diacylglycerols to accumulate fatty acids in the small intestine to suppress biosynthesis of triacylglycerols; antidiabetic agents; insulin resistance; lower blood remnant/leptin level, enhancement of beta -oxidation and uncoupling protein (UCP) expression to promote energy consumption
10/09/2008US20080249154 Preventive and/or Therapeutic Agent For Disease In Which Mitochondrial Benzodiazephine Receptor Participates
10/09/2008US20080249147 Emulsion-Stabilized Preparation
10/09/2008US20080249080 Benzodiazepine Derivatives and Uses Thereof on Medical Field
10/09/2008US20080249054 using a PAT family protein to screen agents for the ability to regulate lipid metabolism; obesity, diabetes [non-insulin and insulin dependent], hypertension, coronary artery disease, hyperlipidemia, hypolipidemia, lipid metabolism disorders, lipid deposition disorders, lipodystrophies
10/09/2008US20080249050 Providing mammalian cell contacted with agent and adeno-associated virus (AAV), identifying agent that when contacted with mammalian cell enhances AAV transduction after viral binding to membrane of contacted mammalian cell and before second strand synthesis which yields expressible form of viral genome
10/09/2008US20080249049 for the delivery of nucleic acid to target cells or tissues; poly(amino acid), polysaccharide, polyester, polyether, polyurethane or vinyl polymer
10/09/2008US20080249046 MODIFIED siRNA MOLECULES AND USES THEREOF
10/09/2008US20080249045 MGAL: A GAL Gene Switch-Based Suite of Methods for Protein Analyses and Protein Expression in Multicellular Organisms and Cells Therefrom
10/09/2008US20080249043 Methods and Compositions Involving Protein Kinase C-Delta
10/09/2008US20080249041 Gene expression inhibition; sustained release; for reduction of neuronal cell death, inflammation, and scar formation; improves wound healing, skin rejuvenation and thickening
10/09/2008US20080249040 Molecules having sense and antisense strands; metabolic and cardiovascular disorders; in vivo stability and activity
10/09/2008US20080249029 Administering (S)-N-Methyl-D-phenylalanyl-N-[4-[(aminoiminomethyl)aminol-1-(2-benzothiazolylcarbonyl)butyl-L-prolinamide as a protease activated receptor-2 modulator
10/09/2008US20080249025 Peptide fragments of p21; antiproliferative agents
10/09/2008US20080249020 Human Growth Hormone Treatment Methods
10/09/2008US20080249014 Micro(dia)filtration of a cell homogenate, extracting the retenate using a buffer solution containing at least one detergent, ion exchange, hydroxyapatite column chromatography; Borrelia lipoproteins, membrane proteins; industrial scale
10/09/2008US20080249012 INCREASING LIFE SPAN BY MODULATION OF Smek
1 ... 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 ... 1564